Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades

被引:37
|
作者
Sun, Sue Yazaki [1 ,2 ]
Melamed, Alexander [3 ,4 ,5 ,6 ]
Joseph, Naima T. [3 ,4 ,5 ,6 ]
Gockley, Allison Ann [3 ,4 ,5 ,6 ]
Goldstein, Donald Peter [3 ,4 ,5 ,6 ]
Bernstein, Marilyn R. [3 ,4 ,5 ,6 ]
Horowitz, Neil S. [3 ,4 ,5 ,6 ]
Berkowitz, Ross Stuart [3 ,4 ,5 ,6 ]
机构
[1] UNIFESP Sao Paulo Fed Univ, Dept Obstet, Sao Paulo, SP, Brazil
[2] UNIFESP Sao Paulo Fed Univ, Paulista Sch Med, Sao Paulo Hosp, Trophoblast Dis Ctr, Sao Paulo, SP, Brazil
[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, 75 Francis St, Boston, MA 02115 USA
[4] Donald P Goldstein MD Trophoblast Tumor Registry, New England Trophoblast Dis Ctr, Boston, MA USA
[5] Dana Farber Canc Inst, Harvard Canc Ctr, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
Complete hydatidiform mole; First-trimester pregnancy; Partial hydatidiform mole; Postmolar neoplasia; Vaginal bleeding; EARLY-DIAGNOSIS; MANAGEMENT; NEOPLASIA; PREGNANCY; FEATURES;
D O I
10.1097/IGC.0000000000000608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to compare the clinical presentation and incidence of postmolar gestational trophoblastic neoplasia (GTN) among cases of complete mole (CM) and partial mole (PM) from 1994 to 2013. Methods: This study included all cases of patients with CM and PM from our trophoblastic disease center between 1994 and 2013. Their clinical and pathologic reports were reviewed. Gestational age at evacuation, features of clinical presentation, human chorionic gonadotropin levels, and the rate of progression to GTN were compared. Results: The median gestational age at evacuation was 9 weeks for CM and 12 weeks for PM (P < 0.001). Patients with PM had lower pre-evacuation serum human chorionic gonadotropin levels (P < 0.001), and they were also less likely to present with vaginal bleeding (P < 0.001), biochemical hyperthyroidism (P < 0.001), anemia (P < 0.001), uterine size greater than dates (P < 0.001), and hyperemesis (P = 0.002). Consequently, patients with PM were less likely to have been clinically diagnosed as moles compared with CM prior to uterine evacuation (P < 0.001). The development of GTN occurred in 17.7% (33/186) and 4.1% (7/169) of patients with CM and PM, respectively (P < 0.001). Conclusions: This study indicates that, at our center over the past 20 years, both CM and PM were usually evacuated in the first trimester of pregnancy. Because CM more commonly presents with the signs and symptoms of molar disease than PM, CM is more commonly diagnosed prior to evacuation.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 40 条
  • [21] PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE AFTER A DIPLOID PARTIAL HYDATIDIFORM MOLE COEXISTING WITH A NORMAL LIVING FETUS
    CHEUNG, NYA
    NGAN, HYS
    GHOSH, A
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 38 (03) : 238 - 239
  • [22] CLINICAL APPLICATIONS OF ANALYSIS OF PLASMA CIRCULATING COMPLETE HYDATIDIFORM MOLE PREGNANCY-ASSOCIATED MIRNAS IN PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE
    Fuchi, N.
    Miura, K.
    Hasegawa, Y.
    Abe, S.
    Higashijima, A.
    Miura, S.
    Mishima, H.
    Kinoshita, A.
    Kaneuchi, M.
    Yoshiura, K.
    Masuzaki, H.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1610 - 1610
  • [23] Western Blot Determination of Caspase-3 Apoptotic Activity in Complete Hydatidiform Mole and Persistent Trophoblastic Disease
    Harma, Mehmet Brahim
    Harma, Muge
    Dilsiz, Nihat
    [J]. JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2005, 6 (03) : 226 - 228
  • [24] Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole - Genotyping and chromosome in situ hybridization analysis
    Cheung, ANY
    Khoo, US
    Lai, CYL
    Chan, KYK
    Xue, WC
    Cheng, DKL
    Chiu, PM
    Tsao, SW
    Ngan, HYS
    [J]. CANCER, 2004, 100 (07) : 1411 - 1417
  • [25] Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease
    Duc, HN
    van Trommel, NE
    Sweep, FCGJ
    Massuger, LFAG
    Thomas, CMG
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (01): : 45 - 49
  • [26] Metastatic gestational trophoblastic disease following a complete hydatidiform mole coexistent with an anencephalic fetus diagnosed at 10 weeks' gestation
    Wagner, Sarah A.
    Keeler, Sean M.
    Blank, Stephanie V.
    Timor-Tritsch, Ilan E.
    [J]. JOURNAL OF ULTRASOUND IN MEDICINE, 2008, 27 (10) : 1533 - 1536
  • [27] RISK OF PERSISTENT TROPHOBLASTIC DISEASE AND CHANCE OF HEALTHY BABY IN TWIN PREGNANCIES WITH COMPLETE HYDATIDIFORM MOLE AND NORMAL CO-TWIN
    Niemann, I.
    Fisher, R.
    Short, D.
    Sebire, N.
    Everad, J.
    Wells, M.
    Savage, P.
    Seckl, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [28] Term delivery of a complete hydatidiform mole with a coexisting living fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease
    Peng, Hsiu-Huei
    Huang, Kuan-Gen
    Chueh, Ho-Yen
    Adlan, Aizura-Syafinaz
    Chang, Shuenn-Dyn
    Lee, Chyi-Long
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2014, 53 (03): : 397 - 400
  • [29] Clinical applications of analysis of plasma circulating complete hydatidiform mole pregnancy-associated miRNAs in gestational trophoblastic neoplasia: A preliminary investigation
    Miura, K.
    Hasegawa, Y.
    Abe, S.
    Higashijima, A.
    Miura, S.
    Mishima, H.
    Kinoshita, A.
    Kaneuchi, M.
    Yoshiura, K.
    Masuzaki, H.
    [J]. PLACENTA, 2014, 35 (09) : 787 - 789
  • [30] Management of a complete hydatidiform mole with a coexisting live fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease: learning points
    Mok, Zhun Wei
    Merchant, Khurshid
    Yip, Swee Lin
    [J]. BMJ CASE REPORTS, 2021, 14 (01)